Taking Stock
Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:45
- Mas informaciones
Informações:
Sinopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.
